Seino, Y., Kaku, K., Kadowaki, T., Okamoto, T., Sato, A., Shirakawa, M., . . . Kaufman, K. D. (2021). A randomized, placebo‐controlled trial to assess the efficacy and safety of sitagliptin in Japanese patients with type 2 diabetes and inadequate glycaemic control on ipragliflozin. Diabetes Obes Metab.
Chicago Style CitationSeino, Yutaka, Kohei Kaku, Takashi Kadowaki, Taro Okamoto, Asako Sato, Masayoshi Shirakawa, Edward A. O'Neill, Samuel S. Engel, i Keith D. Kaufman. "A Randomized, Placebo‐controlled Trial to Assess the Efficacy and Safety of Sitagliptin in Japanese Patients With Type 2 Diabetes and Inadequate Glycaemic Control On Ipragliflozin." Diabetes Obes Metab 2021.
Cita MLASeino, Yutaka, et al. "A Randomized, Placebo‐controlled Trial to Assess the Efficacy and Safety of Sitagliptin in Japanese Patients With Type 2 Diabetes and Inadequate Glycaemic Control On Ipragliflozin." Diabetes Obes Metab 2021.